FERRARESE, CARLO
 Distribuzione geografica
Continente #
NA - Nord America 42.957
EU - Europa 22.512
AS - Asia 10.376
SA - Sud America 693
Continente sconosciuto - Info sul continente non disponibili 62
AF - Africa 61
OC - Oceania 34
Totale 76.695
Nazione #
US - Stati Uniti d'America 42.183
IT - Italia 5.858
SG - Singapore 4.072
DE - Germania 3.485
CN - Cina 3.276
SE - Svezia 3.024
IE - Irlanda 2.426
RU - Federazione Russa 1.976
UA - Ucraina 1.921
HK - Hong Kong 1.437
GB - Regno Unito 1.175
CA - Canada 734
FI - Finlandia 689
BR - Brasile 582
AT - Austria 503
FR - Francia 368
VN - Vietnam 354
IN - India 349
NL - Olanda 261
TR - Turchia 239
ID - Indonesia 227
DK - Danimarca 194
BE - Belgio 185
PL - Polonia 111
IR - Iran 86
JP - Giappone 83
CZ - Repubblica Ceca 65
EU - Europa 55
ES - Italia 48
KR - Corea 39
CH - Svizzera 38
AR - Argentina 27
AU - Australia 27
MX - Messico 27
PT - Portogallo 24
CL - Cile 22
GR - Grecia 21
RO - Romania 20
PK - Pakistan 19
BD - Bangladesh 17
NO - Norvegia 17
IQ - Iraq 16
PH - Filippine 16
UZ - Uzbekistan 15
BG - Bulgaria 14
IL - Israele 14
LT - Lituania 14
PE - Perù 14
VE - Venezuela 13
AL - Albania 12
EG - Egitto 12
EC - Ecuador 11
HU - Ungheria 11
LV - Lettonia 11
AE - Emirati Arabi Uniti 10
AZ - Azerbaigian 10
MY - Malesia 10
ZA - Sudafrica 10
TW - Taiwan 9
KZ - Kazakistan 8
MA - Marocco 8
PA - Panama 8
SA - Arabia Saudita 8
TH - Thailandia 8
CO - Colombia 7
KE - Kenya 7
KG - Kirghizistan 7
NZ - Nuova Zelanda 7
A2 - ???statistics.table.value.countryCode.A2??? 6
EE - Estonia 6
MD - Moldavia 6
PY - Paraguay 6
UY - Uruguay 6
BO - Bolivia 5
JO - Giordania 5
LU - Lussemburgo 5
MT - Malta 5
MU - Mauritius 5
OM - Oman 5
SK - Slovacchia (Repubblica Slovacca) 5
AM - Armenia 4
MN - Mongolia 4
NP - Nepal 4
PS - Palestinian Territory 4
SC - Seychelles 4
CI - Costa d'Avorio 3
GE - Georgia 3
HR - Croazia 3
LA - Repubblica Popolare Democratica del Laos 3
LB - Libano 3
SN - Senegal 3
TN - Tunisia 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
GA - Gabon 2
LK - Sri Lanka 2
MM - Myanmar 2
NI - Nicaragua 2
Totale 76.676
Città #
Ann Arbor 8.919
Woodbridge 4.248
Chandler 3.100
Fairfield 2.819
Singapore 2.663
Houston 2.657
Dublin 2.337
Jacksonville 2.163
Frankfurt am Main 2.111
Ashburn 1.997
Wilmington 1.828
Hong Kong 1.412
Santa Clara 1.412
Milan 1.391
Dearborn 1.368
Seattle 1.191
New York 1.137
Cambridge 999
Princeton 974
Nanjing 556
Shanghai 504
Vienna 452
Lachine 375
Lawrence 368
Beijing 364
Boardman 341
Altamura 324
Helsinki 245
Jakarta 214
Dong Ket 208
San Diego 185
Nanchang 184
Hangzhou 183
Council Bluffs 181
Brussels 175
Munich 173
Shenyang 173
Guangzhou 172
Rome 169
Andover 156
Fremont 139
Los Angeles 139
Toronto 133
Hebei 124
Mountain View 123
Falls Church 118
Ottawa 113
Nuremberg 110
Tianjin 110
Changsha 102
Jinan 97
London 95
Pune 83
Jiaxing 82
Ningbo 76
Lissone 75
Dallas 74
Kraków 74
Grafing 72
Zhengzhou 72
Monza 65
Huizen 61
Norwalk 61
Turin 61
Detroit 57
São Paulo 54
Lappeenranta 49
Brno 47
Kunming 47
Chicago 46
Edmonton 46
Pisa 44
Redmond 43
Carate Brianza 41
San Mateo 40
Como 38
Florence 38
Nürnberg 38
Auburn Hills 37
Hefei 37
Bologna 36
Leawood 35
Naples 35
University Park 34
Lecco 32
Torino 32
Philadelphia 31
Washington 31
Taizhou 29
Amsterdam 26
Bergamo 25
Kocaeli 25
Monmouth Junction 25
Moscow 25
Belo Horizonte 24
Bari 23
Catania 23
Padova 23
Desio 20
Kilburn 20
Totale 53.943
Nome #
The hand pronation phenomenon: a franco-german tale 1.679
ALS Cognitive Behavioral Screen (ALS-CBS): normative values for the Italian population and clinical usability 474
Increased tissue factor pathway inhibitor and homocysteine in Alzheimer's disease 403
Assessing early to late stage dementia: the TSI and BANS-S scales in the nursing-home 402
Using global team science to identify genetic parkinson's disease worldwide 401
Anti-Aβ autoantibodies in cerebral amyloid angiopathy-related inflammation: Implications for amyloid-modifying therapies 383
Bovine spongiform encephalopathy and Creutzfeldt-Jakob disease: facts and uncertainties underlying the causal link between animal and human diseases 368
Cognitive assessment of severe dementia: The test for severe impairment (TSI) 346
Substrate-induced modulation of glutamate uptake in human platelets 339
Increased plasma glutamate in stroke patients might be linked to altered platelet release and uptake 331
Genome-wide Analyses Identify KIF5A as a Novel ALS Gene 331
Head down tilt 15° in experimental intracerebral hemorrhage: a randomized non-inferiority safety trial 329
A Metabolic Imaging Study of Lexical and Phonological Naming Errors in Alzheimer Disease 327
Rotenone down-regulates HSPA8/hsc70 chaperone protein in vitro: A new possible toxic mechanism contributing to Parkinson's disease 326
Cognitive reserve maps the core loci of neurodegeneration in corticobasal degeneration 324
Malattie del Sistema Nervoso 321
TREX1 C-terminal frameshift mutations in the systemic variant of retinal vasculopathy with cerebral leukodystrophy 319
Paradoxical Increase of plasma vitamin B12 and folates with disease severity in anorexia nervosa 302
Multifunctional liposomes interact with Abeta in human biological fluids: Therapeutic implications for Alzheimer's disease 301
null 296
Decreased whole-blood global DNA methylation is related to serum hormones in anorexia nervosa adolescents. 294
Extracorporeal photochemotherapy reduces the severity of Lewis rat experimental allergic encephalomyelitis through a modulation of the function of peripheral blood mononuclear cells 293
THE TOXICITY OF AMYLOID-BETA OLIGOMERS AND TAU HYPERPHOSPHORYLATION ARE PREVENTED FROM LIPID-BASED NANOPARTICLES IN HUMAN PRIMARY FIBOBLASTS 292
Oxidative stress and altered mitochondrial dynamics in neurodegenerative processes 290
HCN ion channels and accessory proteins in epilepsy: genetic analysis of a large cohort of patients and review of the literature 286
Physical anhedonia in Parkinson's disease 279
Serum naturally occurring anti-TDP-43 auto-antibodies are increased in amyotrophic lateral sclerosis 276
Incidence and predictors of acute symptomatic seizures after stroke 276
Irisin and BDNF serum levels and behavioral disturbances in Alzheimer's disease 272
The role of clinical and neuroimaging features in the diagnosis of CADASIL 271
Clinical pregenetic screening for stroke monogenic diseases: Results from lombardia GENS registry 260
Lipid-based nanoparticles counteract the oligomer abeta toxicity and tau phosphorylation in an ex-vivo biomolecular model of alzheimer disease 258
Can Signaling Molecules in Fibroblasts Detect Prodromal Alzheimer's Disease? 256
The one-carbon metabolism in anorexia nervosa of the restrictive type 254
Generation and validation of algorithms to identify subjects with dementia using administrative data 252
Riluzole Selective Antioxidant Effects in Cell Models Expressing Amyotrophic Lateral Sclerosis Endophenotypes 252
Serum DBI and biomarkers of neuroinflammation in Alzheimer's disease and delirium 252
Ischemic Conditions Affect Rerouting of Tau Protein Levels: Evidences for Alteration in Tau Processing and Secretion in Hippocampal Neurons 251
Neurologic outcome of postanoxic refractory status epilepticus after aggressive treatment 249
Atypical parkinsonism and intrathecal anti-glutamic acid decarboxylase antibodies - An unusual association: A case report 249
Reduced platelet glutamate uptake in Parkinson's disease 245
Alpha-synuclein nitration and autophagy response are induced in peripheral blood cells from patients with Parkinson disease 244
Adherence to recommendations and clinical outcomes of patients hospitalized for stroke: the role of the admission ward—a real-life investigation from Italy 243
Glutamatergic Homeostasis Impairment in Multiple Sclerosis Patients 240
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 240
Post-methionine load test: A more sensitive tool to reveal hyperhomocysteinemia in Alzheimer patients? 236
Malattie del Sistema Nervoso 235
Multi-site laser Doppler flowmetry for assessing collateral flow in experimental ischemic stroke: Validation of outcome prediction with acute MRI 235
Inefficient skeletal muscle oxidative function flanks impaired motor neuron recruitment in Amyotrophic Lateral Sclerosis during exercise 235
Clinical, neuropsychological, and morphometric correlates of apathy in Parkinson's disease 234
Beta-amyloid-induced peripheral chemotactic response: what role in Alzheimer’s disease? 233
Guillain-Barré syndrome related to COVID-19 infection 231
Mutual Information Optimization for Mass Spectra Data Alignment 230
Multicentre translational Trial of Remote Ischaemic Conditioning in Acute Ischaemic Stroke (TRICS): protocol of multicentre, parallel group, randomised, preclinical trial in female and male rat and mouse from the Italian Stroke Organization (ISO) Basic Science network 229
Cerebral collateral flow defines topography and evolution of molecular penumbra in experimental ischemic stroke 228
Aβ42 production in brain capillary endothelial cells after oxygen and glucose deprivation 225
Donepezil modulates the endogenous immune response: implications for Alzheimer's disease 225
HSC70 expression is reduced in lymphomonocytes of sporadic ALS patients and contributes to TDP-43 accumulation 224
Benzodiazepine receptors and diazepam-binding inhibitor in human cerebral tumors 216
Rotenone upregulates alpha-synuclein and myocyte enhancer factor 2D independently from lysosomal degradation inhibition 214
Brand new norms for a good old test: Northern Italy normative study of MiniMental State Examination 213
Rotenone-induced down-regulation of HSPA8/hsc70 protein increases alphasynuclein in vitro: possible implications for Parkinson’s disease 212
Increased susceptibility to plasma lipid peroxidation in Alzheimer disease patients 210
Stavudine Reduces NLRP3 Inflammasome Activation and Modulates Amyloid-β Autophagy 210
Diazepam binding inhibitor and dehydroepiandrosterone sulphate plasma levels in borderline personality disorder adolescents. 209
Degenerazione Cortico-Basale: cos’è “corticale” e cosa “basale”? 209
Valproate and HDAC inhibition: A new epigenetic strategy to mitigate phenotypic severity in ALS? 208
Peripheral cytokine release in Alzheimer patients: Correlation with disease severity 207
Micrornas in als: from molecular mechanisms to clinical relevance 207
In vitro study of autophagy dysfunctions associated with Parkinson’s disease 207
Peripheral sink effect as possible nanotherapeutic strategy for alzheimer’s disease: an ex vivo study 206
Cerebrospinal fluid levels of BAFF and APRIL in untreated multiple sclerosis 203
Nonfibrillar Abeta 1-42 inhibits glutamate uptake and phosphorylates p38 in human fibroblasts 203
Impairment of glutamate transport and increased vulnerability to oxidative stress in neuroblastoma SH-SY5Y cells expressing a Cu,Zn superoxide dismutase typical of familial amyotrophic lateral sclerosis 202
Oxidative stress impairs glutamate uptake in fibroblasts from patients with Alzheimer's disease 202
Intracranial collateral flow defines the boundaries of molecular penumbra in experimental ischemic stroke 202
Primary Whipple disease of the Central Nervous System presenting with rhombencephalitis 202
Validation of the Italian version of the ALS cognitive-behavioral screen (ALS-CBS): preliminary results 200
High-dose atorvastatin after stroke or transient ischemic attack 198
Valproate induces epigenetic modifications in lymphomonocytes from epileptic patients 198
An unusual transthyretin gene missense mutation (TTR Phe33Val) linked to familial amyloidotic polyneuropathy 197
Cerebral collateral therapeutics in acute ischemic stroke: A randomized preclinical trial of four modulation strategies 196
Study of alpha-synuclein and its catabolic pathways in ex vivo cells of patients with Parkinson’s disease 195
Posterior reversible encephalopathy syndrome (PRES) associated with acute pancreatitis 195
Cerebellar hematoma in a carrier of the A3243G MELAS mutation 194
Idiopathic infratentorial superficial siderosis of the central nervous system: case report and review of literature 194
Human platelets express the synaptic markers VGLUT1 and 2 and release glutamate following aggregation 192
Novel neurofibromatosis type 2 mutation presenting with status epilepticus 192
Enhanced folate binding of cultured fibroblasts from Alzheimer's disease patients 191
Who is really blind in the time of coronavirus: the patient or the doctor? A rare case of Balint’s syndrome 191
Temporal lobe dysfunction in late-onset epilepsy of unknown origin 191
Alterede miRNA in Amyotrophic Lateral Sclerosis: Searching for the Lowest Common Multiple 190
Neuroligand binding endophenotypes in blood cells distinguish two subsets of borderline personality disorder patients 189
Vesicular monoamine transporter 2 mRNA levels are reduced in platelets from patients with Parkinson's disease 188
Behavioural anomalies in neurodegenerative diseases: role of the immune response 188
Modulation of mapk phosphorylation in fibroblasts from alzheimer patients: erk involvment in glutamate transport and tau hyperphosporylation 188
Platelet glutamate uptake as peripheral marker of excitotoxicity in neurodegenerative disorders 187
Reduced fasting plasma levels of diazepam-binding inhibitor in adolescents with anorexia nervosa. 186
Headache in cerebral venous thrombosis associated with extracranial tumors: a clinical series 186
A case of classic neuromyelitis optica (Devic's syndrome) triggered by pegylated-interferon α 185
Totale 26.229
Categoria #
all - tutte 277.510
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 277.510


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.791 0 0 0 0 0 0 0 0 0 726 831 234
2020/20219.813 692 459 1.051 1.051 739 702 967 763 883 1.049 561 896
2021/20226.886 636 684 879 606 489 564 290 327 356 420 561 1.074
2022/202311.884 1.308 3.449 1.029 1.224 814 1.758 163 642 834 113 330 220
2023/20248.692 308 302 443 447 1.080 2.142 1.569 365 546 205 246 1.039
2024/202512.533 1.140 2.268 1.206 852 1.689 1.270 1.237 844 1.997 30 0 0
Totale 79.532